INTERNATIONAL PATENT: THE CHINESE UNIVERSITY OF HONG KONG FILES APPLICATION FOR "USE OF RGMB AS A TARGET FOR TREATMENT OF KIDNEY DISEASES"

GENEVA, March 24 -- THE CHINESE UNIVERSITY OF HONG KONG (Shatin, New Territories,Hong Kong 999077) filed a patent application (PCT/CN2024/108447) for "USE OF RGMb AS A TARGET FOR TREATMENT OF KIDNEY DISEASES" on Jul 30, 2024. With publication no. WO/2025/055577, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XIA, Yin (c/o The Chinese University of Hong Kong, Shatin, New Territories,Hong Kong), KONG, Yonglun (c/o The Chinese University of Hong Kong, Shatin, New Territories,Hong Kong), ZHANG, Xiaoyi (c/o The Chinese Univer...